Suppr超能文献

抑郁症患者垂体对促甲状腺激素释放激素的反应:综述

Pituitary responses to thyrotropin releasing hormone in depressed patients: a review.

作者信息

Loosen P T, Prange A J, Wilson I C, Lara P P

出版信息

Pharmacol Biochem Behav. 1976;5(Suppl 1):95-101. doi: 10.1016/0091-3057(76)90335-x.

Abstract

Numerous studies show that most depressed patients show abnormal pituitary responses to challenge by intravenous injection of thyrotropin releasing hormone (TRH). Some patients show after TRH diminished thyroid stimulating hormone (TSH) release, some show unexpected growth hormone release; prolactin release may be increased or decreased. The diminished TSH release is the most widely reported finding. It cannot be accounted for by primary changes in the pituitary or thyroid glands. Interference with TRH-induced TSH release by elevated cortisol may account for some observations, but this possibility has not been studied. The present data provide additional evidence that in depression there is often a disruption of hypothalamic regulatory function.

摘要

大量研究表明,大多数抑郁症患者在静脉注射促甲状腺激素释放激素(TRH)进行激发试验时,垂体反应异常。一些患者在注射TRH后促甲状腺激素(TSH)释放减少,一些患者出现意外的生长激素释放;催乳素释放可能增加或减少。TSH释放减少是报道最为广泛的发现。这不能用垂体或甲状腺的原发性改变来解释。皮质醇升高对TRH诱导的TSH释放的干扰可能解释了一些观察结果,但这种可能性尚未得到研究。目前的数据提供了更多证据,表明抑郁症患者下丘脑调节功能常遭破坏。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验